Shen Yang Fuyang Medicine Technology Co., Ltd.

China

Back to Profile

1-2 of 2 for Shen Yang Fuyang Medicine Technology Co., Ltd. Sort by
Query
Aggregations
Jurisdiction
        United States 1
        Canada 1
IPC Class
C12N 1/21 - BacteriaCulture media therefor modified by introduction of foreign genetic material 2
C12N 15/76 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for ActinomycesVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Streptomyces 2
C12N 1/20 - BacteriaCulture media therefor 1
C12N 15/63 - Introduction of foreign genetic material using vectorsVectorsUse of hosts thereforRegulation of expression 1
C12N 15/70 - Vectors or expression systems specially adapted for E. coli 1
See more
Found results for  patents

1.

Genetically engineered strain WSJ-IA for producing isovaleryl spiramycin I

      
Application Number 13811340
Grant Number 08759032
Status In Force
Filing Date 2011-07-21
First Publication Date 2013-05-23
Grant Date 2014-06-24
Owner SHEN YANG FUYANG MEDICINE TECHNOLOGY CO., LTD (China)
Inventor
  • Wang, Yiguang
  • Jiang, Yang
  • Yang, Shengwu
  • Zhao, Xiaofeng

Abstract

A genetically engineered strain WSJ-IA for producing isovaleryl spiramycin I. Also provided is a method for preparing the strain, including the steps of: (a) constructing a recombinant plasmid including a double gene ist-acyB2; (b) transforming the plasmid into an isovaleryl spiramycin I-producing strain to obtain the strain WSJ-IA. The level of isovaleryl spiramycin I produced by fermentation of the strain WSJ-IA is increased 1.7 times and the fermentation potency thereof increased 4.14 times in comparison with the strain exclusively including a single gene ist.

IPC Classes  ?

  • C12P 19/62 - Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
  • C12P 19/60 - Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
  • C12P 19/44 - Preparation of O-glycosides, e.g. glucosides
  • C12N 1/21 - BacteriaCulture media therefor modified by introduction of foreign genetic material
  • C12R 1/465 - Streptomyces
  • C12N 1/20 - BacteriaCulture media therefor
  • C12N 15/70 - Vectors or expression systems specially adapted for E. coli
  • C12N 15/76 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for ActinomycesVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Streptomyces
  • C12N 9/10 - Transferases (2.)

2.

GENETICALLY ENGINEERED STRAIN WSJ-IA FOR PRODUCING ISOVALERYL SPIRAMYCIN I

      
Document Number 02800326
Status In Force
Filing Date 2011-07-21
Grant Date 2014-09-30
Owner SHEN YANG FUYANG MEDICINE TECHNOLOGY CO., LTD. (China)
Inventor
  • Wang, Yiguang
  • Jiang, Yang
  • Yang, Shengwu
  • Zhao, Xiaofeng

Abstract


A genetically engineered strain WSJ-IA for producing isovaleryl spiramycin I.
Also provided is a method for
preparing the strain, comprising the steps of: (a) constructing a recombinant
plasmid comprising a double gene ist-acyB2; (b)
transforming the plasmid into an isovaleryl spiramycin I - producing strain to
obtain the strain WSJ-IA. The level of isovaleryl
spiramycin I produced by fermentation of the strain WSJ-IA is increased 1.7
times and the fermentation potency thereof increased
4.14 times in comparison with the strain exclusively comprising a single gene
ist.


IPC Classes  ?

  • C12N 1/21 - BacteriaCulture media therefor modified by introduction of foreign genetic material
  • C12N 15/63 - Introduction of foreign genetic material using vectorsVectorsUse of hosts thereforRegulation of expression
  • C12N 15/76 - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for ActinomycesVectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Streptomyces